Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1959 1
1960 1
1961 1
1962 4
1963 2
1964 2
1965 3
1966 4
1967 7
1968 3
1969 6
1970 3
1971 6
1972 4
1973 6
1974 4
1975 12
1976 5
1977 5
1978 8
1979 7
1980 8
1981 11
1982 12
1983 7
1984 9
1985 15
1986 18
1987 18
1988 23
1989 13
1990 10
1991 9
1992 9
1993 17
1994 18
1995 16
1996 12
1997 23
1998 31
1999 27
2000 14
2001 22
2002 20
2003 25
2004 25
2005 21
2006 18
2007 13
2008 14
2009 39
2010 37
2011 43
2012 46
2013 39
2014 41
2015 45
2016 50
2017 47
2018 54
2019 49
2020 51
2021 17
Text availability
Article attribute
Article type
Publication date

Search Results

1,058 results
Results by year
Filters applied: . Clear all
Page 1
A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice.
Roberts MN, Wallace MA, Tomilov AA, Zhou Z, Marcotte GR, Tran D, Perez G, Gutierrez-Casado E, Koike S, Knotts TA, Imai DM, Griffey SM, Kim K, Hagopian K, McMackin MZ, Haj FG, Baar K, Cortopassi GA, Ramsey JJ, Lopez-Dominguez JA. Roberts MN, et al. Among authors: koike s. Cell Metab. 2017 Sep 5;26(3):539-546.e5. doi: 10.1016/j.cmet.2017.08.005. Cell Metab. 2017. PMID: 28877457 Free PMC article.
Cellular receptors for enterovirus A71.
Kobayashi K, Koike S. Kobayashi K, et al. Among authors: koike s. J Biomed Sci. 2020 Jan 10;27(1):23. doi: 10.1186/s12929-020-0615-9. J Biomed Sci. 2020. PMID: 31924205 Free PMC article. Review.
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.
Katayama R, Gong B, Togashi N, Miyamoto M, Kiga M, Iwasaki S, Kamai Y, Tominaga Y, Takeda Y, Kagoshima Y, Shimizu Y, Seto Y, Oh-Hara T, Koike S, Nakao N, Hanzawa H, Watanabe K, Yoda S, Yanagitani N, Hata AN, Shaw AT, Nishio M, Fujita N, Isoyama T. Katayama R, et al. Among authors: koike s. Nat Commun. 2019 Aug 9;10(1):3604. doi: 10.1038/s41467-019-11496-z. Nat Commun. 2019. PMID: 31399568 Free PMC article.
Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance.
Okada K, Araki M, Sakashita T, Ma B, Kanada R, Yanagitani N, Horiike A, Koike S, Oh-Hara T, Watanabe K, Tamai K, Maemondo M, Nishio M, Ishikawa T, Okuno Y, Fujita N, Katayama R. Okada K, et al. Among authors: koike s. EBioMedicine. 2019 Mar;41:105-119. doi: 10.1016/j.ebiom.2019.01.019. Epub 2019 Jan 17. EBioMedicine. 2019. PMID: 30662002 Free PMC article.
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer.
Katayama R, Kobayashi Y, Friboulet L, Lockerman EL, Koike S, Shaw AT, Engelman JA, Fujita N. Katayama R, et al. Among authors: koike s. Clin Cancer Res. 2015 Jan 1;21(1):166-74. doi: 10.1158/1078-0432.CCR-14-1385. Epub 2014 Oct 28. Clin Cancer Res. 2015. PMID: 25351743 Free PMC article.
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase-positive non-small cell lung cancer and the clinical responses based on the resistant mechanisms.
Yanagitani N, Uchibori K, Koike S, Tsukahara M, Kitazono S, Yoshizawa T, Horiike A, Ohyanagi F, Tambo Y, Nishikawa S, Fujita N, Katayama R, Nishio M. Yanagitani N, et al. Among authors: koike s. Cancer Sci. 2020 Mar;111(3):932-939. doi: 10.1111/cas.14314. Epub 2020 Feb 8. Cancer Sci. 2020. PMID: 31961053 Free PMC article.
1,058 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page